Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

CRISPR Technology Accelerates

Posted by hunter@stemsave.com on May 9, 2018 9:00:00 AM

crispr-cas9-cancer-command-center-1

A collaborative effort between researchers at Stanford University, the Joint Institute of Metrology and Biology, and the National Institute of Standards and Technology has developed a modified and more targeted version of CRISPR, which is more efficient at editing single nucleotide mutations. The new system is called MAGESTIC (multiplexed, accurate genome-editing through short, trackable, integrated cellular barcodes), and it has been shown to successfully modify genes by accurately targeting the location of defective genes. MAGESTIC ameliorates and addresses the current shortcomings of gene-editing technology by enhancing the ability of CRISPR to target single genes [out of millions] with the purpose of correcting specific mutations.

CRISPR technologies are being utilized to develop treatments for millions of people suffering from genetic disorders, and working in conjunction with stem cells, with the aim of producing long-term cures, as opposed to temporary fixes. For more information on CRISPR, visit our vlog.

Topics: stem cell therapy, CRISPR, Genetic Diseases, genetic engineering

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Recent Posts

Posts by Topic

see all